Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11901 - 11925 of 12986 in total
Experimental
Matched Iupac: … 1-[(2-fluorophenyl)(4-fluorophenyl)phenylmethyl]-1H-imidazole …
Experimental
Matched Iupac: … dialuminium(3+) ion 2-(acetyloxy)benzoic acid trioxidandiide …
Experimental
Matched Iupac: … lambda2-iron(2+) ion (2R,3R)-2,3-dihydroxybutanedioate …
Fludeoxyglucose is under investigation in clinical trial NCT03262389 (Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma).
Investigational
Matched Iupac: … (2R,3S,4R,5R)-2-fluoro-3,4,5,6-tetrahydroxyhexanal …
Zingerone is a pungent component of ginger.
Experimental
Matched Iupac: … 4-(4-hydroxy-3-methoxyphenyl)butan-2-one …
Experimental
Matched Iupac: … 10-[2-(pyrrolidin-1-yl)ethyl]-10H-phenothiazine …
Experimental
Matched Iupac: … (1R,2S)-2-(methylamino)-1-phenylpropyl 4-oxopentanoate …
Fasoracetam is under investigation in clinical trial NCT03609619 (PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without Mglur Mutations).
Investigational
Matched Iupac: … (5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one …
Experimental
Matched Iupac: … ethyl 4-[2-(piperidin-1-yl)acetamido]benzoate …
Cathine, also known as d-norpseudoephedrine and (+)-norpseudoephedrine, is a psychoactive drug with stimulant properties. It belongs to the phenethylamine and amphetamine chemical classes. In the United States, it is classified as a Schedule IV controlled substance.
Experimental
Illicit
Matched Iupac: … (1S,2S)-2-amino-1-phenylpropan-1-ol …
Experimental
Matched Iupac: … (2R)-1-(4-methylbenzenesulfonyl)pyrrolidine-2-carboxylic acid …
Experimental
Matched Iupac: … (1R,4R)-1,7,7-trimethylbicyclo[2.2.1]heptane-2-thione …
Experimental
Matched Iupac: … (2R)-2-amino-3-[(dihydroxyarsanyl)sulfanyl]propanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-(4-iodophenyl)propanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-3-(4-benzoylphenyl)propanoic acid …
Indalpine was one of the first selective serotonin reuptake inhibitors to reach the American market. It was initially marketed by Pharmuka. However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported hematological effects caused by Indalpine, it was abruptly withdrawn from the US market.
Investigational
Withdrawn
Matched Iupac: … 3-[2-(piperidin-4-yl)ethyl]-1H-indole …
CP-39,332 is a serotonin-norepinephrine reuptake inhibitor (SNRI). It is part of a group of monoamine reuptake inhibitor stereoisomers including tametraline (1R,4S-), CP-24,442 (1S,4R-), CP-22,185 (cis-), and CP-22,186 that show varying efficiency. However, none of the members of this stereoisomers has been marketed.
Experimental
Matched Iupac: … N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine …
AZD3043 has been used in trials studying the treatment and basic science of Safety, Sedation, Tolerability, and Pharmacokinetics.
Investigational
Matched Iupac: … propyl 2-{4-[(diethylcarbamoyl)methoxy]-3-ethoxyphenyl}acetate …
Experimental
Matched Iupac: … 3-[2-(diethylamino)ethyl]-3-phenylpiperidine-2,6-dione …
Experimental
Matched Iupac: … 4-[1-hydroxy-2-(methylamino)ethyl]-2,6-dimethoxyphenol …
Experimental
Matched Iupac: … (1R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one …
Investigational
Matched Iupac: … 1-(2-hydroxy-4-methoxyphenyl)ethan-1-one …
6-diazo-5-oxo-L-norleucine is a broad-acting glutamine antagonist.
Investigational
Matched Iupac: … (2S)-2-amino-6-diazo-5-oxohexanoic acid …
Investigational
Matched Iupac: … }phenyl)piperazin-1-yl]phenyl}-3-(propan-2-yl)imidazolidin-2-one ... 1-{4-[4-(4-{[(2S,4R)-4-(2,4-difluorophenyl)-4-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-dioxolan-2-yl]methoxy …
Experimental
Matched Iupac: … -2-enamido]pentanoate ... -2-yl]propyl}(oxido)carbamoyl)-3-methylbut-3-en-1-yl (2S)-2-acetamido-5-[(2E)-5-hydroxy-3-methyl-N-oxidopent ... iron(3+) (3E)-4-({3-[(2S,5S)-5-{3-[(2E)-5-hydroxy-3-methyl-N-oxidopent-2-enamido]propyl}-3,6-dioxopiperazin …
Displaying drugs 11901 - 11925 of 12986 in total